首页> 外文期刊>Protein Expression and Purification >Expression and purification of recombinant human receptor for advanced glycation endproducts in Escherichia coli
【24h】

Expression and purification of recombinant human receptor for advanced glycation endproducts in Escherichia coli

机译:晚期糖基化终产物的重组人受体在大肠杆菌中的表达和纯化

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The receptor for advanced glycation endproducts (RAGE) is a multiligand receptor that binds a variety of structurally and functionally unrelated ligands, including advanced glycation endproducts (AGEs), amyloid fibrils, amphoterin, and members of the SIN family of proteins. The receptor has been implicated in the pathology of diabetes as well as in inflammatory processes and tumor cell metastasis. For the present study, the extracellular region of RAGE (exRAGE) was expressed as a soluble, C-terminal hexahistidine-tagged fusion protein in the periplasmic space of Escherichia coli. Proper processing and folding of the purified protein, predicted to contain three immunoglobulin-type domains, was supported by the results of electrospray mass spectroscopy and circular dichroism experiments. Sedimentation velocity experiments showed that exRAGE was primarily monomeric in solution. Binding to several RAGE ligands, including AGE-BSA, immunoglobulin light chain amyloid fibrils, and glycosaminoglycans, was demonstrated using pull-down, dot-blot, or enzyme-linked microplate assays. Using surface plasmon resonance, the interaction of exRAGE with AGE-BSA was shown to fit a two-site model, with K-D values of 88 nM and 1.4 mu M. The E. coli-derived exRAGE did not bind the advanced glycation endproduct N-epsilon-(carboxymethyl)lysine, as reported for the cellular receptor, and the possible role of RAGE glycosylation in recognition of this ligand is discussed. This new RAGE construct will facilitate detailed studies of RAGE-ligand interactions and provides a platform for preparation of site-directed mutants for future structure/function studies. (c) 2006 Elsevier Inc. All rights reserved.
机译:晚期糖基化终产物(RAGE)的受体是一种多配体受体,可与多种结构和功能上不相关的配体结合,包括高级糖基化终产物(AGEs),淀粉样原纤维,两性蛋白和SIN家族蛋白。该受体与糖尿病的病理以及炎症过程和肿瘤细胞转移有关。对于本研究,RAGE(exRAGE)的细胞外区域在大肠杆菌的周质空间中表达为可溶性的,C端带有六组氨酸标签的融合蛋白。电喷雾质谱和圆二色性实验的结果支持了预计包含三个免疫球蛋白型结构域的纯化蛋白的正确加工和折叠。沉降速度实验表明,exRAGE在溶液中主要为单体。使用下拉,斑点印迹或酶联微孔板检测证明了与几种RAGE配体的结合,包括AGE-BSA,免疫球蛋白轻链淀粉样蛋白原和糖胺聚糖。使用表面等离子体共振,显示exRAGE与AGE-BSA的相互作用符合两点模型,KD值为88 nM和1.4μM。大肠杆菌衍生的exRAGE不结合高级糖基化终产物N-讨论了针对细胞受体的ε-(羧甲基)赖氨酸,以及RAGE糖基化在识别该配体中的可能作用。这种新的RAGE构建体将促进RAGE-配体相互作用的详细研究,并为未来结构/功能研究的定点突变体的制备提供平台。 (c)2006 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号